MedTrace Logo

Identification of Heritable CTEPH

NCT03579862 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2022-10-18

No results posted yet for this study

Summary

Some patients who have blood clots come down with a life-threatening condition known as Chronic Thromboembolic Pulmonary Hypertension (CTEPH), which is high blood pressure only in the arteries of the lungs. This study seeks to understand more about the genetics causes of CTEPH by obtaining blood samples and examining family histories.

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension

Interventions

OTHER

Blood Draw

Sponsors & Collaborators

  • Intermountain Health Care, Inc.

    lead OTHER

Principal Investigators

  • Mark Dodson, MD · Intermountain Health Care, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-25
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03579862 on ClinicalTrials.gov